Related Experiment Video
Updated: Aug 10, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
[Interferon treatment of HCV-correlated active chronic hepatitis and hepatic cirrhosis: personal experience]
1Presidio Ospedaliero S. Leonardo, Unità Epato-Biliare, ASL NA 5-Castellammare di Stabia, Naples.
Background And Aims:
IFN therapy is the only method of treating HCV-correlated active chronic hepatitis given that Ribavirin is still undergoing clinical trials.
Methods:
A total of 166 patients received treatment: 73 (aged <50 years) with active chronic hepatitis and 45 (aged <50) with CHILD hepatic cirrhosis; 24 patients were used as a control group. The first group was treated with alpha-IFN and the second with beta-IFN.
Results:
The complete response was evaluated at 12 months and the sustained response at 18 months using chi2 according to Yates. Highly significant results (p<0.001) were obtained in the two groups compared to controls, but no statistically significant differences were observed between the various alpha-IFN subgroups. Treatment with alpha-IFN and beta-IFN was effective in reducing indices of cytolysis and viral activities.
Conclusions:
IFN treatment positively alters the hepatic histological evolution: the authors affirm that even in advanced cases of chronic liver disease, treatment with IFN may slow down the natural evolution of the disease.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology

